Christian Britschgi - Department of Medical Oncology and Haematology University Hospital Zurich Zurich Switzerland

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Data from Tepotinib Efficacy and Safety in Patients with <i>MET</i> Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice

Xiuning Le,Hiroshi Sakai,Enriqueta Felip, Remi Veillon,Marina Chiara Garassino,Jo Raskin,Alexis B. Cortot,Santiago Viteri,Julien Mazieres, Egbert F. Smit,Michael Thomas,Wade T. Iams,

crossref（2023）

引用0浏览0引用

Supplementary Data from Tepotinib Efficacy and Safety in Patients with <i>MET</i> Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice

Xiuning Le,Hiroshi Sakai,Enriqueta Felip, Remi Veillon,Marina Chiara Garassino,Jo Raskin, Alexis B. Cortot,Santiago Viteri,Julien Mazieres, Egbert F. Smit,Michael Thomas,Wade T. Iams,

crossref（2023）

引用0浏览0引用

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma

Lara Planas-Paz, Alicia Pliego-Mendieta, Catherine Hagedorn,Domingo Aguilera-Garcia,Martina Haberecker,Fabian Arnold, Marius Herzog, Lorenz Bankel,Roman Guggenberger,Sabrina Steiner, Yanjiang Chen,Abdullah Kahraman,

EMBO Mol Med（2023）

引用0浏览0WOS引用

Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial

Enriqueta Felip,Egbert F Smit,Miguel A Molina-Vila,Urania Dafni,Bartomeu Massuti,Thierry Berghmans,Filippo de Marinis,Francesco Passiglia,Anne-Marie C Dingemans,Manuel Cobo,Santiago Viteri,Christian Britschgi,

Lung Cancer（2022）

引用2浏览0WOS引用

MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards

Abdullah Kahraman,Fabian M Arnold, Jacob Hanimann,Marta Nowak, Chantal Pauli,Christian Britschgi,Holger Moch, Martin Zoche

JCO Clin Cancer Inform（2022）

引用0浏览0WOS引用

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management

Remi Veillon,Hiroshi Sakai,Xiuning Le,Enriqueta Felip, Alexis B Cortot,Egbert F Smit,Keunchil Park, Frank Griesinger,Christian Britschgi,Yi-Long Wu,Barbara Melosky, Shobhit Baijal,

Clinical Lung Cancer（2022）

引用0浏览0WOS引用

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

Dilara Akhoundova, Saskia Hussung,Smruthy Sivakumar, Antonia Topfer, Markus Rechsteiner,Abdullah Kahraman, Fabian Arnold, Florian Angst,Christian Britschgi,Martin Zoche,Holger Moch, Achim Weber,

INTERNATIONAL JOURNAL OF CANCERno. 12 (2022): 2161-2171

引用4浏览0WOS引用

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

R A Soo, J-Y Han,U Dafni, B C Cho, C M Yeo, E Nadal, E Carcereny, J de Castro, M A Sala, R Bernabé, L Coate,M Provencio Pulla,

Annals of Oncology（2022）

引用36浏览0WOS引用

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

Markus Joerger, Yannis Metaxas,Khalil Zaman,Olivier Michielin,Nicolas Mach, Adrienne Bettini,Andreas M Schmitt,Nathan Cantoni,Clemens B Caspar, Sonja Stettler, Roma Malval,Miklos Pless,

CANCERS（2022）

引用2浏览0WOS引用

Structure-based prediction of BRAF mutation classes using machine-learning approaches

Fanny S Krebs,Christian Britschgi, Sylvain Pradervand, Rita Achermann,Petros Tsantoulis,Simon Haefliger, Andreas Wicki,Olivier Michielin,Vincent Zoete

SCIENTIFIC REPORTS（2022）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn